Total oxidant and antioxidant status and paraoxonase 1 levels of children with non-cystic fibrosis bronchiectasis.
To evaluate total oxidant status (TOS), total antioxidant capacity (TAC), and paraoxonase 1 (PON1) levels in children with non-cystic fibrosis (CF) bronchiectasis (BE), and to compare these levels with those of healthy controls. The study parameters would also be evaluated according to some demographic, anthropometric, and clinical characteristics, as well as lung functions. Enrolled in the study were 118 children with non-CF BE and 68 healthy controls. Serum TOS, TAC, and PON1 levels were determined. Lung function tests were performed by spirometry. Serum TOS were higher in the patients [median 9.54 (IQR 25-75 = 7.05-13.30) µmolH2O2Eq/L] than in the healthy subjects [6.64 (5.45-9.53) µmolH2O2Eq/L] (P<0.001). TAC was higher in patients with non-CF BE [1.07 (1.0-1.07) mmolTroloxEq/L] than in the healthy controls [0.87 (0.77-0.98) mmolTroloxEq/L] (P<0.001). In addition, serum PON1 levels were significantly higher in the patients [106.5 (42.5-154.2) U/L] than in the controls [47.7 (27.5-82.1) U/L] (P<0.001). The patients with low FEV1 had decreased TAC when compared to those who had normal FEV1 in non-CF BE. The present study demonstrated that compared with the control group, the children with non-CF BE had elevated oxidative status, antioxidant defenses parameters, and PON1 values.